IPCA Laboratories P/B Ratio

Current P/B Ratio
5.56
High Valuation
Very High - Significant premium, high growth expectations or speculative

IPCA Laboratories P/B ratio. IPCA Laboratories (IPCALAB) P/B ratio is 5.56 (High), book value per share ₹3809.60 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see IPCALAB stock price BSE.

Current Valuation Metrics

P/B Ratio 5.56
Current Price ₹1860.00
Book Value/Share ₹3809.60
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹9,524 Cr
Share Capital ₹25 Cr
Reserves & Surplus ₹8,038 Cr
Outstanding Shares 25,000,000
Book Value per Share ₹3809.60

Valuation Signal

Signal Overvalued
Historical Avg 0.46
Historical Range 0.38 - 0.55
Percentile 100.0%

Sector Context

Sector Average -0.3
Sector Median 0.39
Sector Rank #11 of 50
Sector Percentile 22.0%

IPCALAB P/B Ratio — Valuation Insights & Book Value Analysis

IPCA Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 5.56 (High). Browse IPCALAB financial statements for revenue, profit, balance sheet and cash flow data.

  • Stock appears overvalued with PB of 5.56, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 1103.5% above historical average
  • Trading at premium to sector average PB of -0.3

IPCA Laboratories P/B Ratio Historical Trend

IPCALAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read IPCALAB ex-dividend dates for the complete payout history and dividend yield track record.

IPCALAB Historical P/B Ratio — Book Value Per Share & Year-End Price

IPCA Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.49 ₹3809.6 ₹1860.00 ₹9,524 Low
2025 0.42 ₹3355.2 ₹1418.90 ₹8,388 Low
2024 0.55 ₹3090.8 ₹1695.20 ₹7,727 Low
2023 0.47 ₹2366.0 ₹1113.15 ₹5,915 Low
2022 0.38 ₹2227.6 ₹843.10 ₹5,569 Low

IPCALAB vs Healthcare Peers — P/B Ratio Comparison

IPCA Laboratories P/B 5.56 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.

Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Chennai Meenakshi Multis… CMMHOSP -7.62 ₹27 Low
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹39 Low
Krebs Biochemicals & Ind… KREBSBIO -0.75 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹43 Low